Literature DB >> 6454750

Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.

E H Van Elven, A G Rolink, F V Veen, E Gleichmann.   

Abstract

When comparing, in a murine model, the kind of graft-versus-host (GVH) disease (GVHD) induced by the donor strain DBA/2 on the one hand and several H-2-congenic resistant B10 donor strains on the other, we found that strain DBA/2 was a universal nonkilling GVH donor for H-2-incompatible nonirradiated F1 hybrid recipients. In this respect, DBA/2 T cells differed from those of the H-2-identical donor strain B10.D2 as well as those of other b10 donor strains. The inability of strain DBA/2 to kill by GVH reaction was not limited to certain H-2 incompatibilities in the F1 recipients, but was nonspecific. The inability to kill is determined by a dominant locus not linked to H-2. DBA/2 T cells were also incapable of inducing the severe suppression of hematocrit values, bone marrow erythropoiesis, thymic cell proliferation, and splenic IgG production in the F1 recipients that was observed after the injection of T cell from the B10 strains. However, DBA/2 T cells, in contrast with those of the B10 donor strains, were vigorous stimulators of IgG production in H-2-incompatible F1 hybrid recipients. Surprisingly, strain DBA/2 as well as the B10 donor strains had good capacity to generate anti-F1 TK cells. Taken together, these findings raise the possibility that lethal GVHD disease is not caused, or not caused exclusively, by donor killer T cells, but by those donor T cells that directly or indirectly induce a suppression of cell proliferation in certain vital organs of the recipient.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454750      PMCID: PMC2186178          DOI: 10.1084/jem.153.6.1474

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Thymus-derived lymphocytes: their distribution and role in the development of peripheral lymphoid tissues of the mouse.

Authors:  M C Raff; J J Owen
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Lymphopoietic potential of bone marrow cells from aged mice: comparison of the cellular constituents of bone marrow from young and aged mice.

Authors:  J J Farrar; B E Loughman; A A Nordin
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Immunologic induction of malignant lymphoma: genetic factors in the graft-versus-host model.

Authors:  E Gleichmann; H Gleichmann; R S Schwartz
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells.

Authors:  J Sprent; J F Miller
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

6.  Autoimmunity in chronic graft-versus-host disease.

Authors:  P J Fialkow; C Gilchrist; A C Allison
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

7.  Erythropoietic shifts in the graft vs host reaction.

Authors:  E Pinno; G O Bain; L A Campbell
Journal:  Arch Pathol       Date:  1969-09

8.  Development of host plasma cells during graft-versus-host reactions in mice.

Authors:  L Lindholm; L Rydberg; O Strannegård
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

9.  The property of "strength" of histocompatibility antigens, and their ability to produce antigenic competition.

Authors:  W Lawrence; M Simonsen
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

10.  Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis.

Authors:  H Gleichmann; E Gleichmann; J André-Schwartz; R S Schwartz
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  22 in total

1.  Experimental studies of immunologically mediated enteropathy. V. Destructive enteropathy during an acute graft-versus-host reaction in adult BDF1 mice.

Authors:  A M Mowat; M V Felstein
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

2.  Murine chronic graft-versus-host disease as a model for lupus nephritis.

Authors:  J A Bruijn; E H van Elven; P C Hogendoorn; W E Corver; P J Hoedemaeker; G J Fleuren
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

3.  Sex-dependent effects of non-H-2 loci on lethal GVH reaction induced across an H-2 barrier.

Authors:  O Halle-Pannenko; J Y Mary; R Motta
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Graft-versus-host reaction enhanced by ultraviolet radiation.

Authors:  T Kitajima; S Imamura
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

5.  H-2-Restricted lethal graft-versus-host diseases.

Authors:  B Kindred
Journal:  Immunogenetics       Date:  1981-12       Impact factor: 2.846

6.  Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice.

Authors:  S Strobel; A M Mowat; A Ferguson
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

7.  Manipulation of brain DNA synthesis is achieved by using a systemic immunological disease.

Authors:  W S Griffin; E N Crom; J R Head
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Clonal analysis of the T lymphocytes involved in parent versus F1 graft-versus-host reaction.

Authors:  P F Piguet
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.

Authors:  Y Ikarashi; K Kawai; H Watanabe; Y Matsumoto; S Omata; M Fujiwara
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

10.  The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation.

Authors:  R A Puliaev; I A Puliaeva; A E Ryan; C S Via
Journal:  Curr Med Chem Immunol Endocr Metab Agents       Date:  2005-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.